Literature DB >> 6262352

An interchangeable ELISA for cytomegalovirus antigen and antibody.

V A Sundqvist, B Wahren.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) was developed to demonstrate cytomegalovirus (CMV) antibodies and antigen. A nuclear antigen from CMV-infected cells was used for detection of IgG and IgM antibodies. Significant rises of CMV-IgG and significant levels of CMV-IgM were found in sera from patients with acute CMV only, and not with other herpesvirus infections. CMV antigens were demonstrated in cells and in culture medium by a sandwich or by an inhibition ELISA technique. In the sandwich technique, the plates were coated with monkey anti-CMV IgG and rabbit anti-CMV IgG was used as the second antibody. Both early and late CMV antigens were identified with this method. Treatment of CMV containing samples using freeze--thawing or detergent reduced the infectivity, but the antigenicity was not affected. There was no cross-reactivity with herpes simplex or varicella-zoster virus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6262352     DOI: 10.1016/0166-0934(81)90029-x

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  33 in total

1.  Development of a quadriplex polymerase chain reaction for human cytomegalovirus detection.

Authors:  P Markoulatos; V Samara; N Siafakas; E Plakokefalos; N Spyrou; M L Moncany
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  Cytomegalovirus glycoprotein B-specific antibody analysis using electrochemiluminescence detection-based techniques.

Authors:  M Ohlin; M Silvestri; V A Sundqvist; C A Borrebaeck
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

3.  Lymphocyte and IgG responses to different herpes simplex virus antigens in patients with frequent HSV-1 reactivations.

Authors:  P Ljungman; L Zetterqvist; V A Sundqvist; S Jeansson; A Heimdahl; B Wahren
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

4.  Fluctuation of virus antibody levels in healthy adults.

Authors:  O Meurman; O P Lehtonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

5.  Activity of the cytomegalovirus genome in the presence of PPi analogs.

Authors:  B Wahren; U Rudén; H Gadler; B Oberg; B Eriksson
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

6.  Monocyte and iscom enhancement of cell-mediated response to cytomegalovirus.

Authors:  B Wahren; S Nordlund; A Akesson; V A Sundqvist; B Morein
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

7.  Phenotypic study of CD4+ and CD8+ lymphocyte subsets in relation to cytomegalovirus carrier status and its correlate with pokeweed mitogen-induced B lymphocyte differentiation.

Authors:  J W Gratama; R A Langelaar; M A Oosterveer; J A van der Linden; A den Ouden-Noordermeer; A M Naipal; J W Visser; G C de Gast; H J Tanke
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

8.  Postpartum activation of autoimmunity: transient increase of total IgG levels in normal women and in women with autoimmune thyroiditis.

Authors:  R Jansson; F A Karlsson; A Linde; O Sjöberg
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

9.  Development of specific antibody patterns and clinical symptoms following Ockelbo virus infection.

Authors:  S Vene; C Franzén; B Niklasson
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

10.  Evaluation of a synthetic-peptide enzyme-linked immunosorbent assay for immunoglobulin M to human parvovirus B19.

Authors:  E Fridell; B J Cohen; B Wahren
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.